Want to see TSE:DR full AI Analyst Report?
DR Stock Chart & Stats
C$17.91
C$0.22(1.23%)
At close: 4:00 PM EDT
C$17.91
C$0.22(1.23%)
Day’s Range― - ―
52-Week RangeC$13.59 - C$18.79
Previous CloseN/A
Volume7.77K
Average Volume (3M)28.55K
Market Cap
C$239.62M
Enterprise ValueC$321.35
Total Cash (Recent Filing)C$64.01M
Total Debt (Recent Filing)C$54.60M
Price to Earnings (P/E)8.3
Beta0.44
Next Earnings
Nov 05, 2026EPS Estimate
0.17Next Dividend Ex-DateN/A
Dividend Yield2.43%
Share Statistics
EPS (TTM)1.28
Shares Outstanding16,212,750
10 Day Avg. Volume25,496
30 Day Avg. Volume28,554
Financial Highlights & Ratios
PEG Ratio1.82
Price to Book (P/B)2.99
Price to Sales (P/S)0.87
P/FCF Ratio5.49
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$19.00Price Target Upside6.09% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)1.98
Revenue Forecast (FY)C$272.13M
Bulls Say, Bears Say
Bulls Say
Strong Free Cash FlowRobust free cash flow generation and high cash conversion (FCF ≈88% of net income) provide durable internal funding to support capital returns, reinvestment in facilities, and selective M&A or physician recruitment without relying on external debt, improving long-term financial flexibility.
Improved Operating MarginsSustained elevated operating margins and recent profitability improvement reflect efficient facility-level operations and favorable case mix. Higher margins create a buffer against reimbursement pressure and cost inflation, supporting cash generation and ability to maintain investments in staff and specialty services.
Strong Liquidity & No Corporate DebtA healthy cash balance, positive net working capital and absence of corporate-level bank debt afford steady liquidity and balance-sheet flexibility. This structural strength supports sustained capital returns, weathering reimbursement cycles, and targeted investments in physician recruitment or facility upgrades.
Bears Say
Revenue Contraction & VolatilityOngoing TTM revenue decline and repeated top-line volatility weaken earnings visibility and cash predictability. For a model tied to procedure volumes and case mix, sustained revenue contraction reduces margin sustainability and complicates multi-quarter planning for staffing, capital, and shareholder returns.
Rising Operating CostsMaterial increases in drugs, supplies and labor are structural headwinds that can erode margins if volumes or higher-value case mix don't expand. Persistent cost inflation pressures unit economics at surgical facilities and may force tradeoffs between staffing, service mix, and profitability over the medium term.
Weakness In Key Procedure VolumesSignificant declines in inpatient and observation volumes, and sharp pain-management drops, highlight exposure to specialty and physician-driven demand. Recovery depends on successful recruitment and durable referral relationships; prolonged shortfalls would pressure revenue, utilization and long-term facility economics.
Medical Facilities News
DR FAQ
What was Medical Facilities Corporation’s price range in the past 12 months?
Medical Facilities Corporation lowest stock price was C$13.59 and its highest was C$18.79 in the past 12 months.
What is Medical Facilities Corporation’s market cap?
Medical Facilities Corporation’s market cap is C$239.62M.
When is Medical Facilities Corporation’s upcoming earnings report date?
Medical Facilities Corporation’s upcoming earnings report date is Nov 05, 2026 which is in 83 days.
How were Medical Facilities Corporation’s earnings last quarter?
Medical Facilities Corporation released its earnings results on Aug 06, 2026. The company reported C$0.125 earnings per share for the quarter, missing the consensus estimate of C$0.251 by -C$0.125.
Is Medical Facilities Corporation overvalued?
According to Wall Street analysts Medical Facilities Corporation’s price is currently Undervalued.
Does Medical Facilities Corporation pay dividends?
Medical Facilities Corporation pays a Quarterly dividend of C$0.09 which represents an annual dividend yield of 2.43%. See more information on Medical Facilities Corporation dividends here
What is Medical Facilities Corporation’s EPS estimate?
Medical Facilities Corporation’s EPS estimate is 0.17.
How many shares outstanding does Medical Facilities Corporation have?
Medical Facilities Corporation has 16,212,750 shares outstanding.
What happened to Medical Facilities Corporation’s price movement after its last earnings report?
Medical Facilities Corporation reported an EPS of C$0.125 in its last earnings report, missing expectations of C$0.251. Following the earnings report the stock price went down -6.25%.
Which hedge fund is a major shareholder of Medical Facilities Corporation?
Currently, no hedge funds are holding shares in TSE:DR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Medical Facilities Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
2.52%
12-Months-Change
Fundamentals
Return on Equity
2.43%
Trailing 12-Months
Asset Growth
-6.65%
Trailing 12-Months
Company Description
Medical Facilities Corporation
Medical Facilities Corporation (MFC) is engaged in the ownership and management of a network of specialized surgical hospitals and an outpatient surgery facility across the United States. These surgical hospitals deliver a comprehensive range of medical services, encompassing various surgical procedures, diagnostic imaging, general diagnostics, and pain management interventions. Additionally, they provide supplementary services such as immediate care and workplace health. The company's ambulatory surgery center is specifically designed for performing scheduled surgical operations that do not require an overnight stay. MFC was established in 2004 and maintains its corporate headquarters in Toronto, Canada.
DR Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a generally positive operational and financial update: revenue, income from operations, and EBITDA all grew year-over-year, liquidity is strong with no corporate-level debt, and shareholder returns remain substantial via buybacks. However, the company faces notable volume softness in certain categories (inpatient, observation, pain management), and operating costs rose materially, which temper the outlook. Overall the positives—top-line and profit growth, strong cash position, and committed capital returns—outweigh the headwinds from volume mix and expense pressures.View all TSE:DR earnings summariesDR Stock 12 Month Forecast
Average Price Target
C$19.00
▲(6.09% Upside)